NantHealth (NantHealth) GF Value : $8.02 (As of May. 06, 2024)

View and export this data going back to 2016. Start your Free Trial

What is NantHealth GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-06), NantHealth's share price is $1.45. NantHealth's GF Value is $8.02. Therefore, NantHealth's Price-to-GF-Value for today is 0.18.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes NantHealth is Possible Value Trap, Think Twice.

NantHealth (OTCPK:NHIQ) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

NantHealth's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	1.45	/	8.02
	=	0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NantHealth GF Value Related Terms

Thank you for viewing the detailed overview of NantHealth's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

NantHealth (NantHealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NantHealth Inc (OTCPK:NHIQ) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

3000 RDU Center Drive, Suite 200, Morrisville, NC, USA, 27500

Website

https://www.nanthealth.com

NantHealth Inc is a healthcare company that employs precision medicine and technology to give physicians, payers, and patients more information. The company develops software and hardware to collect, indexes, analyze and interpret molecular, financial, clinical, and operational data points to improve decision-making. The company provides cancer care solutions, provide solutions, and payer solutions.

Executives

Rao Haris Naseem	director, 10 percent owner, officer: Chief Executive Officer	C/O NANTHEALTH, INC., 760 W. FIRE TOWER RD., SUITE 107, WINTERVILLE NC 28590
Summus Holdings Llc	10 percent owner	2871 LAKE VISTA DR, SUITE 210, LEWISVILLE TX 75067
Ronald Allen Louks	officer: Chief Operating Officer	C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Nant Capital, Llc	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Patrick Soon-shiong	director, 10 percent owner, officer: See Remarks	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Deanna L. Wise	director	C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD, CULVER CITY CA 90232
Bob Petrou	officer: Interim CFO	C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Mp 13 Ventures, Llc	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Cambridge Equities, Lp	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Allscripts Healthcare Solutions, Inc.	10 percent owner	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Nantworks, Llc	10 percent owner	9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Investment Office Kuwait	10 percent owner	15 CARTER LANE, LONDON X0 EC4V 5EY
Miller Edward D Jr	director	JOHNS HOPKINS, 733 NORTH BROADWAY - SUITE 100, BALTIMORE MD 21205
Kuwait Investment Authority On Behalf Of The Govt Of Kuwait	10 percent owner	C/O HOMEPLACE OF AMERICA INC, 3200 POTTERY DRIVE, MYRTLE BEACH SC 29579
James Mark Burnett	director	640 N. SEPULVEDA BLVD., LOS ANGELES CA 90049